Not logged in Share Save
Share Save
Harmonizing cerebrospinal fluid analysis for multiple sclerosis investigation: An update from the hCAMI subcommittee of the Canadian Society of Clinical Chemists (CSCC) Higgins, Victoria; Beriault, Daniel; Parker, Michelle; Bhayana, Vipin; Booth, Ronald; Chen, Yu; Collier, Christine; Gagne, Myriam; Gifford, Jessica; Ismail, Ola; Macri, Joseph; Newbigging, Ashley; Olayinka, Lily; Rodriguez-Capote, Karina; Yang, Liju; Freedman, Mark; Moore, Craig; Poliakov, Ilia; Schneider, Raphael; Thebault, Simon Share Save
Share Save
Share Save
Comparison of vision-related quality of life in NMOSD and MOGAD Gassan, Adnan A.; Konig, Andrea; Nisenbaum, Rosane; Freedman, Mark S.; Lee, Liesly; Marrie, Ruth Ann; Mccombe, Jennifer A.; Micieli, Jonathan; Morrow, Sarah A.; Parks, Natalie E.; Smyth, Penelope; Rotstein, Dalia L. Share Save
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis Hartung, Hans-Peter; Benedict, Ralph H. B.; Berger, Thomas; Bermel, Robert A.; Brochet, Bruno; Carroll, William M.; Freedman, Mark S.; Holmoy, Trygve; Karabudak, Rana; Nos, Carlos; Patti, Francesco; Perrin Ross, Amy; Vanopdenbosch, Ludo; Vollmer, Timothy; Wuerfel, Jens; Clinch, Susanne; Kadner, Karen; Kuenzel, Thomas; Kulyk, Inessa; Raposo, Catarina; Thanei, Gian-Andrea; Killestein, Joep Share Save
Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort Giovannoni, Gavin; Boyko, Alexey; Correale, Jorge; Edan, Gilles; Freedman, Mark S.; Montalban, Xavier; Rammohan, Kottil; Stefoski, Dusan; Yamout, Bassem; Leist, Thomas; Aydemir, Aida; Borsi, Laszlo; di Cantogno, Elisabetta Verdun Share Save
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD Rotstein, Dalia L.; Freedman, Mark S.; Konig, Andrea; Lee, Liesly; Luo, Jin; Maxwell, Colleen; Morrow, Sarah A.; Tremlett, Helen; Vyas, Manav V.; Marrie, Ruth Ann Share Save
Neurofilaments as biomarkers in neurological disorders - towards clinical application Khalil, Michael; Teunissen, Charlotte E.; Lehmann, Sylvain; Otto, Markus; Piehl, Fredrik; Ziemssen, Tjalf; Bittner, Stefan; Sormani, Maria Pia; Gattringer, Thomas; Abu-Rumeileh, Samir; Thebault, Simon; Abdelhak, Ahmed; Green, Ari; Benkert, Pascal; Kappos, Ludwig; Comabella, Manuel; Tumani, Hayrettin; Freedman, Mark S.; Petzold, Axel; Blennow, Kaj; Zetterberg, Henrik; Leppert, David; Kuhle, Jens Share Save
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis Kalincik, Tomas; Sharmin, Sifat; Roos, Izanne; Massey, Jennifer; Sutton, Ian; Withers, Barbara; Freedman, Mark S.; Atkins, Harold; Krasulova, Eva; Havrdova, Eva Kubala; Trneny, Marek; Kozak, Tomas; Burman, Joachim; Macdonell, Richard; Torkildsen, Oivind; Bo, Lars; Lehmann, Anne Kristine; Sharrack, Basil; Snowden, John Share Save
Share Save
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives Freedman, Mark S.; Coyle, Patricia K.; Hellwig, Kerstin; Singer, Barry; Wynn, Daniel; Weinstock-Guttman, Bianca; Markovic-Plese, Silva; Galazka, Andrew; Dangond, Fernando; Korich, Julie; Reder, Anthony T. Share Save
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study Singer, Barry A.; Arnold, Douglas L.; Drulovic, Jelena; Freedman, Mark S.; Gold, Ralf; Gudesblatt, Mark; Jasinska, Elzbieta; Laganke, Christopher C.; Naismith, Robert T.; Negroski, Donald; Oh, Jiwon; Perez, Miguel Angel Hernandez; Selmaj, Krzysztof; Bergh, Florian Then; Wundes, Annette; Ziemssen, Tjalf; Castro-Borrero, Wanda; Chen, Hailu; Levin, Seth; Scaramozza, Matthew; Shankar, Sai L.; Wang, Ting; Wray, Sibyl Share Save
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis Spain, Rebecca I.; Hildebrand, Andrea; Waslo, Carin S.; Rooney, William D.; Emmons, Joshua; Schwartz, Daniel L.; Freedman, Mark S.; Paz Soldan, M. Mateo; Repovic, Pavle; Solomon, Andrew J.; Rinker II, John; Wallin, Mitchell; Haselkorn, Jodie K.; Stuve, Olaf; Gross, Robert H.; Turner, Aaron P. Share Save
Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis Jiang, Tammy; Ziemssen, Tjalf; Wray, Sibyl; Shen, Changyu; Soderbarg, Karin; Lewin, James B.; Bozin, Ivan; Freedman, Mark S. Share Save
Share Save
Pregnancy Outcomes and Disease Course in NMOSD and MOGAD in CANOPTICS Chu, Laura; Rotstein, Dalia; Freedman, Mark; Konig, Andrea; Lee, Liesly; Marrie, Ruth-Ann; McCombe, Jennifer; Morrow, Sarah; Parks, Natalie; Smyth, Penelope; Krysko, Kristen Share Save
Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-Naive Patients With Early-Stage Relapsing-Remitting Multiple Sclerosis; the Phase IIIb ENSEMBLE Study Bermel, Robert; Hartung, Hans-Peter; Brochet, Bruno; Benedict, Ralph; Berger, Thomas; Carroll, William; Vollmer, Timothy; Holmoy, Trygve; Karabudak, Rana; Killestein, Joep; Nos, Carlos; Patti, Francesco; Ross, Amy Perrin; Vanopdenbosch, Ludo; Wuerfel, Jens; Kuenzel, Thomas; Kadner, Karen; Kulyk, Inessa; Freedman, Mark Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}